• AML Maintenance Part 2: a metaMORPHOsis?

  • 2023/11/08
  • 再生時間： 55 分
  • ポッドキャスト

『AML Maintenance Part 2: a metaMORPHOsis?』のカバーアート

AML Maintenance Part 2: a metaMORPHOsis?

無料で聴く

ポッドキャストの詳細を見る

  • サマリー

  • In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!


    • Sorafenib observational study: https://pubmed.ncbi.nlm.nih.gov/30809038/
    • SORMAIN (sorafenib): https://pubmed.ncbi.nlm.nih.gov/32673171/
    • Chinese Sorafenib Phase III: https://pubmed.ncbi.nlm.nih.gov/32791048/
    • RADIUS (midostaurin): https://pubmed.ncbi.nlm.nih.gov/33288862/
    • AMLSG 16-10 (midostaurin): https://pubmed.ncbi.nlm.nih.gov/30563875/
    • MORPHO (EHA abstract): https://library.ehaweb.org/eha/2023/eha2023-congress/391322/faculty.presenters.bmt-ctn.1506.28morpho29.a.randomized.trial.of.the.flt3.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmorpho
    続きを読む 一部表示

あらすじ・解説

In the second portion of our two part-series on AML maintenance, Anthony and Bernie delve into the studies of post-transplant FLT3 inhibitor maintenance. We discuss the controversial MORPHO study of gilteritinib and whether these results will change practice!


  • Sorafenib observational study: https://pubmed.ncbi.nlm.nih.gov/30809038/
  • SORMAIN (sorafenib): https://pubmed.ncbi.nlm.nih.gov/32673171/
  • Chinese Sorafenib Phase III: https://pubmed.ncbi.nlm.nih.gov/32791048/
  • RADIUS (midostaurin): https://pubmed.ncbi.nlm.nih.gov/33288862/
  • AMLSG 16-10 (midostaurin): https://pubmed.ncbi.nlm.nih.gov/30563875/
  • MORPHO (EHA abstract): https://library.ehaweb.org/eha/2023/eha2023-congress/391322/faculty.presenters.bmt-ctn.1506.28morpho29.a.randomized.trial.of.the.flt3.html?f=listing%3D0%2Abrowseby%3D8%2Asortby%3D1%2Asearch%3Dmorpho
続きを読む 一部表示

AML Maintenance Part 2: a metaMORPHOsis?に寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。